6515--Brand Name or Equal to the Elekta Vantage Deep Brain Stimulation Stereotactic System

The Department of Veterans Affairs, through Network Contracting Office 23, is soliciting a Brand Name or Equal system for the Elekta Vantage Deep Brain Stimulation Stereotactic System to be delivered to the Minneapolis VA Health Care System. The contract under solicitation number 36C26326Q0584 is structured as a firm-fixed-price acquisition with a Low Price Technically Acceptable (LPTA)evaluation method, meaning award will be made to the offeror providing the lowest-priced submission that meets minimum technical requirements. Offerors must submit proposals in two electronic volumes—Pricing and Technical—via email to Theresa Thunder, the primary point of contact, with all submissions due by 10:00 p.m. Eastern Time on May 29, 2026. The period of performance runs from June 1, 2026, to September 30, 2026, with delivery to occur at the Minneapolis VA facility. The contract requires full compliance with functional specifications matching the Leksell Vantage system, compatibility with existing Medtronic equipment, and adherence to detailed packaging, labeling, and barcoding requirements for all equipment. The system must include specific deliverables such as the Stereotactic head frame, NeuroPak Retractor, UltraStim Neuro Monitor, and other ancillary components, each identified by part numbers and serial numbers. Payment will be processed exclusively through the VA’s Electronic Invoice Presentment and Payment (IPP) system using X12 EDI format; WAWF, fax, email, or paper submissions are prohibited. Contractors must enroll in the System for Award Management to receive electronic funds transfers and comply with strict security and technology prohibitions under FAR 52.240-91 and NDAA Section 889, including bans on Kaspersky software, covered telecommunications equipment, and systems originating from sanctioned countries. All personnel accessing the VA facility must complete TMS 20939−No Access training and be escorted by designated biomedical staff. Offerors must self-represent size status and UEI, complete FAR 52.212-3 certifications, and disclose any prohibited product usage within 72 hours of discovery. Amendments to the solicitation will be issued only on the official site, and offerors bear full responsibility for monitoring updates. Failure to follow submission instructions, omit required documentation, or supply non-compliant equipment will result in rejection.